ARDX•benzinga•February 20, 2025 at 12:38 PM

Ardelyx Expects Full Year 2025 Us Net Product Sales Revenue For Ibsrela To Be Between $240M-$250M, Ardelyx Continues To Expect Ibsrela To Achieve Greater Than 10% Market Share At Peak And Generate More Than $1B In Annual U.S. Net Product Sales Revenue Bef

No summary available.

Read the full article from the original source for complete details and context.

Article published on February 20, 2025 by benzinga